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Management of patients with asymptomatic severe aortic
stenosis (AS) and preserved ejection fraction (EF) continues
to puzzle cardiologists. The open questions begin with the
very definition of the lesion. American guidelines require a
valve area 1 cm2 and a mean gradient 40 mm Hg (1,2),
but on the basis of the landmark report of Otto et al. (3), a
peak velocity 4 m/s is also regarded as a marker of severe
stenosis. However, mean gradients are usually approxi-
mately one-half of peak gradients in aortic stenosis, and
thus a 4-m/s peak gradient predicts a peak gradient of 64
mm Hg, which typically will correspond to a mean gradient
lower than 40 mm Hg, the cutoff for severe AS cited in the
See page 235
preceding text. The European guidelines, in turn, use an
even higher 50-mm Hg cutoff for mean gradient in severe
AS (4). Thus the cutoff sets of valve area, mean gradient,
and peak velocity proposed by current guidelines are not
entirely consistent, and a call for lowering the area threshold
to 0.8 cm2 has recently been made (5). Another qualifier
hat at closer scrutiny becomes less clear than desirable is
ormal left ventricular (LV) (systolic) function. American
nd European guidelines use a cutoff for EF of 50%, which is
ell-under 2 SDs of EF in presumably healthy populations (6).
hus, one might infer that in many patients incipient LV
ysfunction is misclassified as “normal.” This is confirmed by
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paper to disclose.ublished data showing early impairment of longitudinal LV
unction in spite of normal EF, presumably signaling LV
brosis (7). Finally, there is the problem of ascertaining
symptomatic status, which is notoriously difficult in the old
opulation of—often comorbid—AS patients.
The study by Lancellotti et al. (8) in this issue of the
ournal offers important new insights. The authors followed
50 patients (mean age: 70 years) with aortic valve area 1
m2, EF 55%, and a normal exercise test over an average of
27 months and examined the occurrence of cardiovascular
mortality and aortic valve replacement, which was planned
according to current guidelines on the basis of 6 or 12 monthly
follow-up visits. Remarkably, no patient was lost to follow-up.
Following a proposition from the Québec group (9),
patients were substratified by their mean gradients (40 or
40 mm Hg) and their stroke volume index (35 or 35
ml/m2), calculated from echo data. Thus, 4 groups were
defined: “normal” stroke volume index with high or low
gradient, and low stroke volume index with high or low
gradient, the latter representing the much discussed “para-
doxical low flow, low gradient severe AS”; the term para-
doxical refers to the intuitive contradiction between normal
EF and low stroke volume index. Furthermore, brain
natriuretic peptide (BNP) levels were measured at baseline.
The 4 groups did not differ significantly in age, sex, body
surface area, LV volumes, or EF. Although significant
differences were present in aortic valve areas, prognosis was
not independently associated with this parameter. By mul-
tivariable analysis, the following baseline parameters
emerged as independently predictive for prognosis: peak
aortic velocities, LV end-diastolic volumes, left atrial vol-
ume (here measured as left atrial area index), the presence of
low stroke volume index, in particular if combined with low
gradients (“paradoxical” AS), and BNP. Some desirable data
are not reported, such as whether low stroke volume index
patients had more concentric remodeling. In the presence of
concentric remodeling a ventricle will, at the same EF, gener-
ate less stroke volume than one with no concentric remodeling.
Furthermore, the presence or absence of pulmonary hyperten-
sion was not reported, which might have impacted prognosis.
The follow-up data reveal several important points.
First, although EF was normal by inclusion criteria in all
groups and EF values did not predict adverse prognosis on
multivariable analysis, low stroke volume index independently
predicted impaired prognosis. This is important, because com-
monly normal EF and normal stroke volume index are taken to
be more-or-less equivalent. However, the present study makes
it likely that EF 50% is too crude a measure of LV function
nd in particular is incapable of reflecting early damage to
ongitudinal myocardial function. Parameters like longitudinal
elocities, mitral annular excursion, or longitudinal strain seem
etter-suited for this task. In fact, longitudinal strain in this
tudy was significantly reduced in the low stroke volume index
roups. Concordantly, BNP levels were higher in the low stroke
olume index groups. This supports the suggestion of the authors
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January 17, 2012:244–5 Subgroups in Aortic Stenosisthat these patients represent a group with more advanced disease,
perhaps with more fibrotic remodeling. Unfortunately, the groups
with low stroke volume index were quite small (n 15 and n
11 in the high and low gradient groups, respectively), somewhat
tempering the strength of the conclusions. Another explanation
for their low stroke volumes could be the significantly increased
valvulo-arterial impedance, a measure of LV afterload, in the
low-stroke volume index groups.
Second, “paradoxical” low stroke volume index, low-
gradient aortic AS was found in 7%. These patients, in spite of
their “moderate” mean gradients of 33  5 mm Hg, had the
worst prognosis of the whole cohort. They had a 5-fold higher
hazard ratio (5.22; 95% confidence interval: 2.02 to 14.1) for
death or aortic valve replacement than patients with 35
l/m2 stroke volume index and high gradients. This is in line
ith other reports on impaired prognosis in paradoxic AS
9,10). However, it contrasts starkly with a recently published
etrospective analysis from the Simvastatin and Ezetimibe in
ortic Stenosis study (11), which reported near-identical
urvival curves for patients with paradoxical AS (aortic valve
rea 1 cm2, mean gradient 40 mm Hg) compared with
atients with moderate AS (aortic valve area 1 to 1.5 cm2,
mean gradient 40 mm Hg), both with normal EF. As the
authors of the present study appropriately point out, patients
with paradoxical severe AS in the Jander et al. (11) study had
lower body size than their comparators, and after correction for
this, their stroke volume index averaged 35 ml/m2, so that
presumably approximately one-half of them did not truly have
low (35 ml/m2) stroke volume index. Furthermore, stroke
olume index calculated from the reportedLV volumes (instead of
V outflow tract stroke volumes) results in even higher values.
oreover, patients were differently selected in the 2 studies.
Third, 3 of 150 patients died suddenly during follow-up.
he incidence of sudden cardiac death in asymptomatic
evere AS has often been debated. Rosenhek et al. (12)
eported 1 sudden death in 123 initially asymptomatic
atients followed over an average of 22 months; Otto et al.
3) saw no sudden death in 123 patients followed over a
ean of 2.5 years. Thus, the study confirms that incidence
f sudden death in such patients, if followed-up regularly
nd carefully, is lower than 1%/year.
How might the results of this study impact the manage-
ent of patients with asymptomatic severe AS (area 1
m2) with preserved EF ? First, it re-emphasizes the utility
of close follow-up (6- to 12-month intervals) and liberal use
of exercise to confirm lack of symptoms. Next, it confirms
that some of these patients have mean gradients 40 mm
Hg (and peak velocities4 m/s), thus not fulfilling standard
guideline criteria. Of these, those with relatively low stroke
volumes (stroke volume index 35 ml/m2) seem to have
worse disease, perhaps more fibrosis, and a worse prognosis.
These are further characterized by impaired longitudinal
function (e.g., lower longitudinal strain but also lower
longitudinal tissue velocities and mitral plane excursion) and
higher BNP levels. Thus, the study also calls for a morecomplete evaluation of AS severity than just the peak and
mean gradient and EF. We must remember, however, that
“composite” parameters like valve area by continuity or
stroke volume suffer from the compounded risks of mea-
surement error. Therefore, the first reflex in the presence of
a surprising, “paradoxic” set of echo data should be critical
review of the raw data, in particular outflow tract diameter
and both continuous-wave and pulsed-wave Doppler signal
quality. If confirmed, these patients should perhaps be
further evaluated with regard to LV longitudinal function
and BNP. Clear guidance as to which cutoffs might prompt
valve replacement is missing so far, but studies like the
present report help making informed individual decisions.
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